Polymeric topology and composition constrained polyether–polyester micelles for directional antitumor drug delivery
Graphical abstract
Introduction
Malignancy (i.e. cancer) is one of the most serious worldwide diseases, threatening human health and longevity [1], [2]. In spite of the vigorous exploitations of various antitumor drugs, their clinical efficacy is unsatisfactory due to their life-threatening side effects, such as leukemia and cardiotoxicity [3]. To reduce the severe side effects, many kinds of nanocarriers, such as micelles [4], [5], [6], [7], vesicles [8], [9] and nanogels [2], [10], have been developed as vehicles to transport antitumor drugs.
It is well known that the amphiphilic copolymers can self-assemble into various nanoscale aggregations, such as micelles [11], [12], [13], [14], [15] and vesicles [16], [17], [18], in the aqueous environment dominated by the topological structures, proportions, compositions and physicochemical properties of both hydrophilic and hydrophobic moieties. For intravenous drug delivery applications, the hydrophilic segments of amphiphilic copolymers are composed of zwitterionic materials or polyethylene glycol (PEG), which can resist nonspecific protein adsorptions (i.e. nonfouling properties) and prolong the circulation times of nanoparticles in the complex in vivo circumstances [19], [20]. Aliphatic polyesters, such as poly(ε-caprolactone) (PCL) [21], polylactide (PLA) [22] and poly(lactide-co-glycolide) (PLGA) [23], are the most commonly chosen hydrophobic moieties that work as the sustained release reservoirs of bioactive agents benefiting from their good biocompatibilities and biodegradabilities. Of all the aforementioned nanovehicles, micelles have emerged as one of the most promising nanocarriers for various antitumor drugs. The micelles are usually associated with several merits as polymeric drug carriers, such as improved drug solubility in water, prolonged circulation time, enhanced accumulation in tumor sites, decreased side effects, and elevated drug bioavailability and efficacy [24], [25], [26].
So far, the major research works have been focused on the micelles based on amphiphilic linear di/triblock copolymers in the realm of drug delivery [27], [28]. As a typical example, the micelles from diblock copolymers of PEG and PLA for delivery of paclitaxel have been approved in Korea (Genexol®-PM) for the treatments of ovarian and metastatic breast cancers, and are in phase IV clinical trials in the USA as a safer alternative to Cremophor® EL and Taxol® [29], [30]. Prostate-specific membrane antigen-targeted PEG–PLA and PEG–PLGA mixed micelles containing docetaxel for the treatment of patients with solid tumors are in ongoing phase II clinical trials [31]. However, the relatively poor stabilities and low drug loading capabilities of micelles based on linearcopolymers affect their wide application as drug carriers [32]. Amphiphilic miktoarm star-shaped copolymers, composing of three or more hydrophilic or hydrophobic arms linked to the same junction point, have attracted much attention because the diverse topologies may improve the properties of micelles [21], [22]. Although many studies on micelles originating from linear or star-shaped copolymers have been undertaken [15], [21], [33], systematic comparisons of the properties of micellar drug carriers made from copolymers with different topologies have rarely been reported [22].
In this study, amphiphilic linear and dumbbell-shaped copolymers composed of hydrophilic PEG and hydrophobic PLGA were efficiently synthesized by the ring-opening polymerization (ROP) of lactide (LA) and glycolide (GA) with PEG or tetrahydroxyl-functionalized PEG ((OH)2–PEG–(OH)2) as the macroinitiator and stannous octoate (Sn(Oct)2) as the catalyst [21], [22]. The obtained copolymers were employed as novel polymeric surfactants, and spontaneously self-assembled into micelles in phosphate-buffered saline (PBS) at pH 7.4. Doxorubicin (DOX), an anthracycline antitumor drug, was loaded into the cores of micelles with tunable drug loading efficiency (DLE) associated with the topologies and compositions of copolymers [15], [22]. In vitro DOX release from DOX-loaded micelles in PBS was revealed to beaccelerated with the linear polymeric topology, the decrease of PLGA content, or in tumor tissular or intracellular acidic condition, which indicated their potential usages as the smart tissular and intracellular targeting drug carriers [34]. The cytocompatibilities and hemocompatibilities of copolymers, and the cellular proliferation inhibitions of DOX-loaded micelles were also revealed to be desirable. These properties indicated that the amphiphilic linear or dumbbell-shaped copolymers were promising vehicle matrices in antitumor drug delivery.
Section snippets
Materials
Poly(ethylene glycol) (PEG90, Mn = 4000) was purchased from Sigma–Aldrich (Steinheim, Germany) without further purification. Dowex 50 W-X2 ion exchange resins were obtained from Sigma–Aldrich (Steinheim, Germany) and used after methanol rinse. 2,2-Dimethoxypropane (DMP; Sinopharm Chemical Reagent Co. Ltd, Shanghai, China), 2,2-bis(hydroxymethyl) propionic acid (BHPA; Sinopharm Chemical Reagent Co. Ltd, Shanghai, China), 4-dimethylamiopryidine (DMAP; GL, Biochem Co. Ltd, Shanghai, China) and Sn(Oct)
Syntheses and characterizations of copolymers
In this work, amphiphilic linear and dumbbell-shaped PEG–PLGA copolymers were synthesized by the ROP of LA and GA with PEG or (OH)2–PEG–(OH)2 as the macroinitiator and Sn(Oct)2 as the catalyst (Scheme S.1, Supporting information, and Scheme 1). The chemical structures of PLGA–PEG–PLGA and PLGA2–PEG–PLGA2 were confirmed by 1H NMR (Fig. S2, Supporting information, and Fig. 1A) and FTIR (Fig. S3, Supporting information, and Fig. 1B) spectra, and GPC chromatograms (Fig. 2). The 1H NMR spectra
Conclusions
Amphiphilic linear and dumbbell-shaped PEG–PLGA copolymers were prepared by the random copolymerization of LA and GA with PEG or (OH)2–PEG–(OH)2 as the macroinitiator and Sn(Oct)2 as the catalyst. The synthesized amphiphilic copolymers were substantiated to have exact chemical structures, controllable molecular weights and amphiphilic properties. The copolymers spontaneously self-assembled into regular micelles in PBS at pH 7.4, which laid the foundation for their application in the field of
Acknowledgements
This research was financially supported by the National Natural Science Foundation of China (Projects 51173184, 51021003, 51273196, 51203153, 21104076, 21004061 and 51273037).
References (42)
- et al.
Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(γ-benzyl l-glutamate) micelles for liver targeting therapy
Acta Biomater
(2010) - et al.
Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG–PE micelles in ovarian cancer cell spheroid model
J Control Release
(2012) - et al.
A complex of cyclohexane-1,2-diaminoplatinum with an amphiphilic biodegradable polymer with pendant carboxyl groups
Acta Biomater
(2012) - et al.
The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles
Biomaterials
(2013) - et al.
Therapeutic efficacy of a lipid-based prodrug of mitomycin C in PEGylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models
J Control Release
(2012) - et al.
Synthesis of temperature and pH-responsive crosslinked micelles from polypeptide-based graft copolymer
J Colloid Interface Sci
(2011) - et al.
Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers
Prog Polym Sci
(2010) - et al.
Synthesis and characterization of star-shaped block copolymer of poly(ε-caprolactone) and poly(ethyl ethylene phosphate) as drug carrier
Polymer
(2008) - et al.
Stimuli-responsive nanoparticles, nanogels and capsules for integrated multifunctional intelligent systems
Prog Polym Sci
(2010) - et al.
Direct formation of cationic polypeptide vesicle as potential carrier for drug and gene
Mater Lett
(2012)
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance
Int J Pharm
The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles
Biomaterials
Novel composite core–shell nanoparticles as busulfan carriers
J Control Release
Toward ‘smart’ nano-objects by self-assembly of block copolymers in solution
Prog Polym Sci
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG–PLGA copolymer nanoparticles
Biomaterials
Biocompatible reduction-responsive polypeptide micelles as nanocarriers for enhanced chemotherapy efficacy in vitro
J Mater Chem B
Intracellular microenvironment responsive PEGylated polypeptide nanogels with ionizable cores for efficient doxorubicin loading and triggered release
J Mater Chem
Multifunctional nanoparticles for targeted chemophotothermal treatment of cancer cells
Angew Chem Int Ed
Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics
Mol Pharm
Targeted nanogels: a versatile platform for drug delivery to tumors
Mol Cancer Ther
Poly(l-glutamic acid) grafted with oligo(2-(2-(2-methoxyethoxy)ethoxy) ethyl methacrylate): thermal phase transition, secondary structure, and self-assembly
J Polym Sci Part A: Polym Chem
Cited by (44)
Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics
2023, Bioactive MaterialsImmunomodulatory nanosystems: An emerging strategy to combat viral infections
2023, Biomaterials and BiosystemsTechnical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method
2017, International Journal of PharmaceuticsCitation Excerpt :Polymers in the retrieved studies either were prepared and characterized in conventional ways (ring opening polymerization, EDC-NHS chemistry) or purchased as a readymade from manufacturers. However, two interesting reports can be commented on; Li et al., has synthesized dumbbell shaped copolymers (PLGA)2PEG(PLGA)2, which showed lower critical micelle concentration (CMC), smaller particle size, higher drug loading and also demonstrated slower in vitro drug release (Li et al., 2013). In another study (PEG)3 PLA copolymer was prepared for the sake of increasing pegylation density, it was reported that this polymer slowed the hydrophilic drug release from the self-assembled micelles (Ayen et al., 2011).
Synthesis, characterisation and phase transition behaviour of temperature-responsive physically crosslinked poly (N-vinylcaprolactam) based polymers for biomedical applications
2017, Materials Science and Engineering CCitation Excerpt :Li et al. studied poly (ethylene glycol)–poly (lactide-co-glycolide) (PEG–PLGA) copolymers Doxorubicin (DOX), loaded into micelles through nanoprecipitation. The in vitro release behaviour could be adjusted by regulating the composition of the copolymer [34]. Studies of PNVCL have focused almost entirely on its behaviour in aqueous media with far fewer studies been done on the polymer in the solid state.
Targeted sustained delivery of antineoplastic agent with multicomponent polylactide stereocomplex micelle
2017, Nanomedicine: Nanotechnology, Biology, and MedicineCitation Excerpt :As shown in Figure 2, C, a similar rapid DOX release of about 30% from SCM/DOX and cRGD-SCM/DOX was observed within 8 h. Subsequently, DOX was released in a steadier pattern, and approximately 50% of DOX was released at 72 h. The initial fast release might be attributed to the dissociation of surface-absorbed drug presented in the hydrophilic shell of micelle, while the sustained release was likely assigned to the slow release of DOX entrapped in the hydrophobic core of micelle.34 It should be noted that about half of the encapsulated drug has not been released in the test duration, which may be associated with the hydrophobic core of micelle tightly, as observed previously.42
PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment
2017, Journal of Colloid and Interface Science
- 1
These authors contributed equally to this work.